Sandra Dodd

Sandra Dodd is an experienced professional in clinical compliance and trial master file (TMF) operations, currently serving as Associate Director, Clinical Compliance & Records at Amylyx Pharmaceuticals since October 2024. Prior to this role, Sandra held positions at Xencor as Head of TMF Operations and at Polaris Pharmaceuticals Inc. as Associate Manager of Clinical Trials. Early career experiences include roles at Eli Lilly and Company, PPD, and Bank of America, where expertise in clinical trial management and banking operations was developed. Sandra Dodd possesses educational credentials in Clinical Trial & Design Management from UC San Diego Extended Studies, and has attended California State University San Marcos and DeVry University.